CD30/TNFRSF8 is a co-stimulatory molecule expressed on activated T and B cells commonly used as a marker for neoplastic cells of cHL, systemic ALCL and CD30+ CLPD [41,57]. The gene discussed is TNFRSF8; the disease is classic Hodgkin lymphoma.